Table 1.
Participant Demographics.
| Variable | Value |
|---|---|
| Age, mean ± SEM, y | 61 ± 3 |
| Height, mean ± SEM, cm | 172 ± 3.0 |
| Mass, mean ± SEM, kg | 91 ± 5.8 |
| BMI | 30.9 ± 2.0 |
| VO2peak mL/kg/min | 17.2 ± 2.1 |
| EF (%) | 32 ± 2.2 |
| Etiology | - |
| Ischemic | 3 |
| Non-Ischemic Dilated Cardiomyopathy | 1 |
| Idiopathic Heart Disease | 1 |
| NYHA Class, n (%) | - |
| Class I | 2 (40) |
| Class II | 3 (60) |
| Comorbidities, n (%) | - |
| Diabetic | 3 (60) |
| HTN | 1 (20) |
| Obese | 4 (80) |
| Drug therapy, n (%) | - |
| Metformin | 1 (20) |
| B-Blockers | 5 (100) |
| ACE Inhibitor | 2 (40) |
| Statin | 3 (60) |
| Aspirin | 4 (80) |
| Diuretics | 3 (60) |
Abbreviations: EF, ejection fraction; NYHA, New York Heart Association; COPD, chronic obstructive pulmonary disease; HTN, hypertension; ACE inhibitor- angiotensin-converting-enzyme inhibitor.